Autoimmun Diagnostika GmbH
 
deutsche version POSITION : Kits >> PCR-Kits >> Alpha-1-Antitrypsin    SEARCHSITEMAPE-MAIL Genom Identification Diagnostics GmbHIMPRESSUM
RDB2010 •  References     
 

Alpha-1-Antitrypsin

RDB2010

Reverse hybridisation assay for the determination of the point mutations PiZ and PiS in the human gene for alpha-1-antitrypsin


 
Alpha-1-Antitrypsin (Pi) is a protease inhibitor, the lack of which is associated with pulmonary and hepatic diseases. The Pi gene is located on the long distal arm of the Chromosome14. With an incidence of 1:1600 the lack of alpha-1-antitrypsin is one of the most frequent hereditary diseases. It is transmitted recessively. The pathogenesis is still unclear, since not all carriers manifest the illness. The results of investigations with twin pairs suggest an influence of exogeneous factors.

Up to 25% of the children with total lack of alpha-1-antitrypsin (homozygous PiZ mutation) develop a cirrhosis of the liver, while about 75% of all adults concerned develop obstructive lung diseases.

PiZ is by far the most frequent of the deficiency alleles with clinical significance. The also frequent PiS allele seems to be relevant only in combination with the PiZ allele. Carriers of PiS alone normally do not get ill.

Heterozygous carriers of PiMZ or PiSZ normally are clinically inconspicious or, with the exception of smokers, only develop a mild form of the illness. Heterozygous carriers who smoke in most cases develop chronical obstructive lung diseases comparable to the symptoms seen in homozygous non-smoking carriers.

The diagnosis is effected by determining the level of alpha-1-antitrypsin in the blood. A significantly diminished concentration of this protein points to homozygositiy of the defect. Heterozygous carriers of the defect mutation show concentrations in the lower region of the normal range. Since alpha-1-antitrypsin is an acute phase protein, even heterozygous carriers may show a slightly increased level during infections or under therapy with estrogens or other steroids. The determination of the alpha-1-antitrypsin level in the blood therefore is unsuitable for the detection of heterozygous carriers. Only the typing of the alpha-1-antitrypsin alleles allows a diagnostic statement.

With the alpha-1-antitrypsin assay from AID homo- and heterozygous carriers can be unmistakably detected and differentiated. Other, mostly irrelevant alleles are not taken into account.


top
References

Eriksson, S. G.
Liver disease in a 1-antitrypsin deficiency.
Scand. J. Gastroenterol. 20: 907 (1985)

Janus, E. D., Phillips, N. T., Carrel, R. W.
Smoking, lung function and a 1-antitrypsin deficiency.
Lancet 1: 152 (1985)

Braun, A., Meyer, P., Cleve, H., Roscher, A. A.
Rapid and simple diagnosis of the two common a 1-proteinase inhibitor deficiency alleles PiZ and PiS by DNA analysis.
Eur. J. Clin. Chem. Clin. Biochem. 34: 761 (1996)

Zuntar, I., Topic, E., Jurcic, Z., Cekada, S.
Genotyping of a1-Antitrypsin S and Z Alleles
Clin. Lab. 44: 837-843 (1998)
top
Infection
Human Genetics
  Hematology
Faktor V / Faktor II + HR 2
Faktor V/II + MTHFR
MTHFR
Hereditary Hemochromatosis
  Immunology
HLA-B*27 + CYP2D6*4
HLA-DRB1 Shared epitope
Celiac disease(HLA-DQ and DR4)
Celiac disease(HLA-DQ2, DQ8 and DR4)
IDDM
  Metabolism
Apolipoprotein E+B (ApoE+ApoB)
Osteoporosis
Alpha-1-Antitrypsin
Lactose intolerance
Fructoseintolerance New!
  Pharmacogenetics
Cytochrom P450 CYP2C19
Cytochrom P450 CYP2C9
Glutathion-S-Transferase
company | imaging devices | kits | references | service | contact | search | sitemap | e-mail | impressum | home

AID GmbH
Ebinger Strasse 4
D-72479 Straßberg


SEARCHSITEMAPE-MAIL Genom Identification Diagnostics GmbHIMPRESSUM